To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland

Abstract

To the Editor:

Murphy et al1 recently published an analysis of the factors influencing the rapid review (RR) outcome in Ireland. The RR process is a pivotal part of the drug appraisal and reimbursement process, and analysis of factors associated with its outcomes is an important research question. RR outcomes may affect the speed of access of new drugs to patients. As members of the National Centre for Pharmacoeconomics (NCPE) Review Group who conduct the evaluations, we wanted to take the opportunity to provide further insight into the process and discuss the article’s findings.

Authors

Helen O’Donnell Felicity Lamrock Lesley Tilson Michael Barry

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×